American Vietnamese Biotech Incorporation マネジメント

マネジメント基準チェック /14

We currently do not have sufficient information about the CEO.

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	7.9yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

American Vietnamese Biotech Incorporation CEOがいない、あるいは彼らに関するデータがない。

取締役

名称	ポジション	在職期間	報酬	所有権
Nguyen Trung	Director	no data	データなし	データなし
Hoang Oanh	Director	no data	データなし	データなし
Bach Ha	Chairman	no data	データなし	データなし
Thi Ha	Chairman of Control Committee	no data	データなし	データなし
Truong Tích	Director	no data	データなし	データなし
Le Ha	Director	no data	データなし	データなし
Dang Giang	Member of Control Committee	no data	データなし	データなし
Vu Ngat	Director	7.9yrs	データなし	データなし
Bui Hao	Director	no data	データなし	データなし
Dang Nhuong	Director	8yrs	データなし	データなし
Nguyen Huyen	Director	no data	データなし	データなし
Pham Tuy	Director	7.9yrs	データなし	3.59% ₫ 8.0b

7.9yrs

平均在職期間

経験豊富なボード: AMV's board of directors are considered experienced (7.9 years average tenure).

American Vietnamese Biotech Incorporation マネジメント

マネジメント基準チェック /14

主要情報

経営陣の近況

No independent directors

No independent directors

Recent updates

New major risk - Market cap size

New minor risk - Share price stability

Second quarter 2024 earnings released

First quarter 2024 earnings released: EPS: ₫12.00 (vs ₫26.00 in 1Q 2023)

Full year 2023 earnings released: EPS: ₫104 (vs ₫502 in FY 2022)

Third quarter 2023 earnings released: EPS: ₫37.00 (vs ₫32.95 in 3Q 2022)

Second quarter 2023 earnings released: EPS: ₫14.00 (vs ₫344 in 2Q 2022)

An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation (HNX:AMV) for VND 29.4 billion.

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₫26.00 (vs ₫240 in 1Q 2022)

Investor sentiment improves as stock rises 17%

No independent directors

No independent directors

An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien.

Full year 2020 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

American Vietnamese Biotech Incorporation (HNX:AMV) agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million.

Full year 2020 earnings released: EPS ₫2,056 (vs ₫4,137 in FY 2019)

Investor sentiment deteriorated over the past week

New 90-day low: ₫10,500

First Dividend Is ₫2,000 Per Share

New 90-day high: ₫18,100

American Vietnamese Biotech Incorporation announced that it has received VND 250 billion in funding

Nguyen Thi Hong Hai acquired 6.63% stake in American Vietnamese Biotech Incorporation (HNX:AMV)

New 90-day low - ₫15,500

CEO（最高経営責任者

取締役

平均在職期間

American Vietnamese Biotech Incorporation マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

No independent directors

No independent directors

Recent updates

New major risk - Market cap size

New minor risk - Share price stability

Second quarter 2024 earnings released

First quarter 2024 earnings released: EPS: ₫12.00 (vs ₫26.00 in 1Q 2023)

Full year 2023 earnings released: EPS: ₫104 (vs ₫502 in FY 2022)

Third quarter 2023 earnings released: EPS: ₫37.00 (vs ₫32.95 in 3Q 2022)

Second quarter 2023 earnings released: EPS: ₫14.00 (vs ₫344 in 2Q 2022)

An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation (HNX:AMV) for VND 29.4 billion.

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₫26.00 (vs ₫240 in 1Q 2022)

Investor sentiment improves as stock rises 17%

No independent directors

No independent directors

An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien.

Full year 2020 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

American Vietnamese Biotech Incorporation (HNX:AMV) agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million.

Full year 2020 earnings released: EPS ₫2,056 (vs ₫4,137 in FY 2019)

Investor sentiment deteriorated over the past week

New 90-day low: ₫10,500

First Dividend Is ₫2,000 Per Share

New 90-day high: ₫18,100

American Vietnamese Biotech Incorporation announced that it has received VND 250 billion in funding

Nguyen Thi Hong Hai acquired 6.63% stake in American Vietnamese Biotech Incorporation (HNX:AMV)

New 90-day low - ₫15,500

CEO（最高経営責任者

取締役

平均在職期間

マネジメント基準チェック /14